glp-1 comparison of short-acting versus long-acting RAs [Meier et al GLP-1 Tablets vs Injection: Effectiveness
Description
310 , E744E753 (2016)
Incapsula incident ID: 926000060406728865-608246272018481588
Liraglutide attenuates nonalcoholic fatty liver disease by modulating gut microbiota in rats administered a high-fat diet
doi: 10.2337/db06-0738
Providers typically prescribe a low starting dose and gradually increase it based on your response and tolerance for side effects
One suggested practice to managing GI AEs is the Three Es method, which comprises 1) education and explanation, 2) escalation to an appropriate dose, and 3) effective management of GI AEs
